首页|期刊导航|中风与神经疾病杂志|血清CXCL16、TNF-α水平及脑小血管病总体负荷与缺血性脑卒中患者神经功能缺损及预后的相关性研究

血清CXCL16、TNF-α水平及脑小血管病总体负荷与缺血性脑卒中患者神经功能缺损及预后的相关性研究OA

Association of serum levels of CXC chemokine ligand 16 and tumor necrosis factor-α and total burden of cerebral small vessel disease with neurological deficit and prognosis in patients with ischemic stroke

中文摘要英文摘要

目的 探究血清CXC趋化因子配体16(CXCL16)、肿瘤坏死因子α(TNF-α)、脑小血管病(CSVD)总体负荷与缺血性脑卒中(AIS)患者神经功能缺损及预后的相关性.方法 选取2022年12月—2024年1月期间于石家庄市人民医院神经内科住院的120例AIS患者作为研究对象,患者均行rt-PA静脉溶栓治疗,根据CSVD总体负荷评分分为轻中度负荷组(n=44例)和重度负荷组(n=76例),于治疗结束90 d后进行随访,采用改良Rankin量表(mRS)评估预后状态,根据预后状态分为预后良好组(n=79例)和预后不良组(n=41例),对比分析不同预后状况患者临床资料,采用Spearman分析纳入的所有AIS患者血清CXCL16、TNF-α水平与美国国立卫生研究院卒中量表(NIHSS)评分、CSVD总体负荷评分的相关性;多因素Logistic分析影响AIS预后状态的相关因素;受试者工作特征曲线(ROC)分析血清CXCL16、TNF-α表达和CSVD总体负荷评分对AIS患者预后状态的预测效能.结果 CSVD总体负荷重度组AIS患者血清CXCL16和TNF-α表达水平均高于轻中度组(P<0.05);预后不良组AIS患者血清CXCL16表达水平高于预后良好组(P<0.05);血清CXCL16、TNF-α表达水平与NIHSS评分(r=0.531、0.741)、CSVD总体负荷评分(r=0.554、0.609)两两之间均呈正相关(P<0.05);预后不良组与预后良好组NIHSS评分≥6分、CSVD总体负荷为重度的患者占比较大,差异有统计学意义(P<0.05);NIHSS评分≥6分(OR=2.669)、CSVD总体负荷为重度(OR=1.960)以及CXCL16(OR=2.219)、TNF-α(OR=2.716)为AIS患者发生不良预后的危险因素(P<0.05);血清CXCL16、TNF-α和CSVD总体负荷评分单独预测AIS患者预后状态的曲线下面积(AUC)分别为0.797、0.772、0.838,而三者联合预测的AUC为0.940,优于各自单独预测(Z联合-CXCL16=2.891、Z联合-TNF-α=4.105、Z联合-CSVD总体负荷评分=2.847,P值分别为0.003 8、0.001 0、0.004 4).结论 AIS患者血清CXCL16、TNF-α表达水平以及CSVD总体负荷与患者神经功能缺损及预后状态有关,三者联合检测对AIS患者的预后状态具有较高的预测效能.

Objective To investigate the association of the serum levels of CXC chemokine ligand 16(CXCL16)and tumor necrosis factor-α(TNF-α)and the total burden of cerebral small vessel disease(CSVD)with neurological defi-cit and prognosis in patients with ischemic stroke(AIS).Methods A total of 120 AIS patients who were hospitalized in Department of Neurology,Shijiazhuang People's Hospital,from December 2022 to January 2024 were enrolled as sub-jects,and all patients underwent intravenous rt-PA thrombolytic therapy.According to the total burden score of CSVD,the patients were divided into mild-to-moderate burden group with 44 patients and severe burden group with 76 patients.The patients were followed up on day 90 after treatment,and modified Rankin Scale(mRS)used to assess prognosis.Ac-cording to the prognosis,the patients were divided into good prognosis group with 79 patients and poor prognosis group with 41 patients,and clinical data were compared be-tween the two groups.A Spearman analysis was used to investigate the correlation of the serum levels of CXCL16 and TNF-α with National Institutes of Health Stroke Scale(NIHSS)score and the total burden score of CSVD in all AIS patients;a multivariate Logistic re-gression analysis was used to investigate the influenc-ing factors for the prognosis of AIS;the receiver oper-ating characteristic(ROC)curve was used to investigate the performance of the serum levels of CXCL16 and TNF-α and the total burden score of CSVD in predicting the prognosis of AIS patients.Results Compared with the mild-to-moderate burden group,the severe burden group had significantly higher serum levels of CXCL16(P<0.05)and TNF-α(P<0.05),and compared with the good prognosis group,the poor prognosis group had significantly higher serum levels of CXCL16(P<0.05)and TNF-α(P<0.05).The serum levels of CXCL16 and TNF-α were positively correlated with NIHSS score(r=0.531 and 0.741,P<0.05)and the total burden score of CSVD(r=0.554 and 0.609,P<0.05).The poor prognosis group had significantly higher proportions of patients with NIHSS score≥6 and severe CSVD total burden than the good prognosis group(P<0.05).NIHSS score≥6(OR=2.669,P<0.05),severe CSVD total burden(OR=1.960,P<0.05),CXCL16(OR=2.219,P<0.05),and TNF-α(OR=2.716,P<0.05)were risk factors for poor progno-sis in AIS patients.Serum CXCL16,serum TNF-α,and CSVD total burden score alone had an area under the ROC curve(AUC)of 0.797,0.772,and 0.838,respectively,in predicting the prognosis of AIS patients,while the combination of these three indicators had an AUC of 0.940,with a better performance than each indicator used alone(Zcombination-CXCL16=2.891,Zcombination-TNF-α=4.105,Zcombination-CSVD total burden score=2.847,P=0.003 8,0.001 0,and 0.004 4).Conclusion The se-rum levels of CXCL16 and TNF-α and the total burden score of CSVD are associated with neurological deficit and progno-sis in AIS patients,and combined measurement of these three indicators has high efficacy in predicting the prognosis of AIS patient.

宋哲;韩中石;王卿;张皓谦

石家庄市人民医院神经内科,河北 石家庄 050000河北省第八人民医院体检科,河北 石家庄 050000河北省第八人民医院急诊科,河北 石家庄 050000正定县人民医院神经内科,河北 石家庄 050800

医药卫生

缺血性脑卒中神经功能CXC趋化因子配体16肿瘤坏死因子α脑小血管病总体负荷预后

Ischemic strokeNeurological functionCXC chemokine ligand 16Tumor necrosis factor-αCerebral small vessel disease total burdenPrognosis

《中风与神经疾病杂志》 2026 (8)

728-733,6

2023年度河北省医学科学研究课题(20231615)

10.19845/j.cnki.zfysjjbzz.2026.0127

评论